pragmaticgame.xyz

Emami Shares Plunge to 52-Week Low Before Recovering on Axiom Acquisition News

Emami Shares Plunge to 52-Week Low Before Recovering on Axiom Acquisition News
Foto: pragmaticgame.xyz

Authored by pragmaticgame.xyz, 03-04-2026

Emami Ltd shares dropped to a 52-week low of Rs 385.5 during Thursday's trading session but closed 1.3 percent higher at Rs 398.5. This volatility coincided with the company's announcement to acquire the remaining 73 percent stake in Axiom Ayurveda Pvt Ltd for up to Rs 200 crore, securing full ownership of the AloFrut beverage brand. The move marks Emami's push into high-growth health and wellness beverages amid shifting consumer preferences.

Strategic Shift into Functional Beverages

Emami's acquisition elevates its initial 27 percent stake in Axiom, taken two and a half years ago, to complete control. Valued at up to Rs 200 crore and set for phased completion over three months, the deal extends beyond personal care into food and beverages. Axiom's portfolio, including AloFrut aloe vera drinks, Axiom Jeevan Ras juices, and Mukti Gold wellness products, aligns with demand for natural health options.

Financial Stability and Growth Trajectory

Axiom reported turnover of Rs 107 crore in FY24 and Rs 110 crore in FY25, showing steady expansion. Under Emami's distribution network, these brands gain access to broader markets. Emami's existing lineup, with over 550 products like Navratna, BoroPlus, and Zandu Balm, creates synergies through cross-selling and shared marketing in wellness categories.

Leadership and Broader FMCG Trends

Axiom appointed Harkirat Bedi as CEO, drawing from his role as Vice President at Dabur Nepal to professionalize operations. This follows Emami's pattern of buying into niches: full ownership of The Man Company in 2024 for male grooming and a stake in Fur Ball Story in 2022 for pet care. The acquisition positions Emami within India's wellness ecosystem, where functional drinks drive growth amid preferences for plant-based and preventive health products.